Enterosys becomes a member of the Pharmabiotic Research Institute (PRI)

Functional ingredients: from plausibility to proof

The functional food market is no longer a niche. The global functional foods market was estimated at $332 billion in 2024 and is expected to grow to $638 billion by 2034, at a CAGR of 6.9%. In North America alone, more than 65% of consumers reported in 2024 actively...

Aging impairs the gut: microbiota, barrier signals and systemic alterations

We often talk about aging in terms of mitochondria, senescent cells, or epigenetics. But there’s a system we still underestimate, one that quietly shapes inflammation, resilience, and even how our organs “age together”: the gut. In fact, scientific frameworks now...

Gut–Skin axis 2.0: why 75 % of gut disorders break out on your skin

Quick recap : what we covered last time In my first newsletter we introduced the gut–skin axis: a two-way biochemical hotline in which intestinal dysbiosis, “leaky-gut” endotoxins and microbially produced metabolites ignite cytokine storms that thin the epidermal...

Gut–skin axis: a scientific rationale for dermatological disorders

In recent years, dermatological research has increasingly turned inward, toward the gut! The concept of the gut–skin axis has gained considerable traction, supported by robust data linking intestinal health and microbial balance to the onset and progression of...

Gut motility: the hidden role of the enteric nervous system

TAKE HOME MESSAGES : The ENS orchestrates gut motility through a complex balance of neural circuits and neurotransmitters. Disruptions in gut motility can trigger systemic metabolic imbalances, contributing to hyperglycemia and insulin resistance. ENS dysfunction is...